Both medications offer a wide range of long-term health improvements, including: Improved blood sugar control : Both drugs help manage blood sugar levels in people with type 2 diabetes, which can prevent complications like neuropathy, kidney disease, and vision loss
The first GLP-1 drug entered the market for the treatment of Type 2 diabetes, with Ozempic following in 2017 and Mounjaro in 2022
doi:10.1016/j.prp.2023.154847
Why: This combination captures the cause of diabetes (post-surgical), the diabetes type, and the long-term therapy status
When you start Ozempic, your body begins a real adjustment phase
mild pruritus may be relieved with a cool compress or oral non-sedating antihistamine